- Home
- BOH vs XENE Comparison
BOH vs XENE Comparison
Compare BOH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOH | XENE |
|---|---|---|
| Founded | 1897 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BOH | XENE |
|---|---|---|
| Price | $73.93 | $42.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $72.00 | $54.09 |
| AVG Volume (30 Days) | 281.2K | ★ 1.0M |
| Earning Date | 01-26-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.78% | N/A |
| EPS Growth | ★ 22.78 | N/A |
| EPS | ★ 4.09 | N/A |
| Revenue | ★ $677,459,000.00 | $7,500,000.00 |
| Revenue This Year | $15.10 | N/A |
| Revenue Next Year | $8.26 | N/A |
| P/E Ratio | $18.10 | ★ N/A |
| Revenue Growth | ★ 8.56 | N/A |
| 52 Week Low | $57.45 | $26.74 |
| 52 Week High | $76.00 | $46.60 |
Technical Indicators
Market Signals| Indicator | BOH | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 66.42 | 50.44 |
| Support Level | $69.95 | $39.29 |
| Resistance Level | $72.40 | $42.00 |
| Average True Range (ATR) | 1.69 | 2.01 |
| MACD | 0.23 | -0.08 |
| Stochastic Oscillator | 88.34 | 50.63 |
Price Performance
Historical ComparisonAbout BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.